John Kitchens, MD, discusses the impact of diabetic eye disease and macular diabetic edema for patients on both a societal standpoint and an individual standpoint.
%jwplayer%
John Kitchens, MD, discusses the impact of diabetic eye disease and macular diabetic edema for patients on both a societal standpoint and an individual standpoint.
Dr Kitchens explains the process of how this disease forms in the back of the eye, what it looks like using Optical Coherence Tomography for imaging purposes and how PharmaCo therapies have had a significant impact on patients. According to Dr Kitchens, macular diabetic edema is the leading cause of vision loss for working age adults in the United States.
“Every day we see patients that come in with proliferative disease that have never been told that their eyes are affected by diabetes. The one thing they say is, ‘If I only knew that my eyes were affected by this, I would have gotten checked.’ And if they would’ve gotten checked, they would have gotten treated at a much, much earlier time frame,” Dr Kitchens said.
“The gap is narrowing a little bit more as we have these treatments that can actually turn back the clock on some of the retinopathy but at the same time, there are patients every day that I see that I wish I would’ve seen 6 to 12 months sooner so we could’ve saved some of their vision.”
Exploring Pharmaceutical Innovations, Trust, and Access With CVS Health's CMO
July 11th 2024On this episode of Managed Care Cast, we're talking with the chief medical officer of CVS Health about recent pharmaceutical innovations, patient-provider relationships, and strategies to reduce drug costs.
Listen
How Can Employers Leverage the DPP to Improve Diabetes Rates?
February 15th 2022On this episode of Managed Care Cast, Jill Hutt, vice president of member services at the Greater Philadelphia Business Coalition on Health, explains the Coalition’s efforts to reduce diabetes rates through the Diabetes Prevention Program (DPP).
Listen